What is the Impact Factor of Therapeutic Advances in Neurological Disorders?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Therapeutic Advances in Neurological Disorders is 4.00, ranking in quartile Q1 of Web of Science (SCIE).

Is Therapeutic Advances in Neurological Disorders indexed in Web of Science or Scopus?

Yes, Therapeutic Advances in Neurological Disorders is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.243 (Q1) and an H-index of 81.

Who publishes Therapeutic Advances in Neurological Disorders and what is the Article Processing Charge (APC)?

Therapeutic Advances in Neurological Disorders is published by SAGE Publications Ltd. The estimated Article Processing Charge (APC) is approximately $3,585 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Therapeutic Advances in Neurological Disorders?

The official ISO-4 abbreviation of Therapeutic Advances in Neurological Disorders is "THER ADV NEUROL DISO". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #3,425Gold OA

Therapeutic Advances in Neurological Disorders

Abbreviation (ISO):THER ADV NEUROL DISO

•

Identifier (ISSN):1756-2856(Print)/1756-2864(Online)

•

Publisher:SAGE Publications Ltd

Official Website Submission Portal Compare

Clarivate IF (2026)

4↓ -0.1

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Therapeutic Advances in Neurological Disorders

WoS Q1

Annual Impact Factor Metric

Current (2026):4

Scopus SJR & RankScopus Q1

1.243

#3,425

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

81 papers with at least that number of citations each

WoS: SCIE / JCRQ1

Self-Citation Rate2.1%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

93articles/year

100% Gold OA•75.32% Original Research

Aims & Scope

Therapeutic Advances in Neurological Disorders is a peer-reviewed, open access journal delivering the highest quality articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of neurology. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in neurology, providing a forum in print and online for publishing the highest quality articles in this area.

Topics Covered (Recognized by AI)

Medicine99.7%Biology91.3%Internal medicine90%Psychology87.5%Pathology78.5%Psychiatry77.9%Immunology51.8%Genetics47.1%Surgery42.8%Disease42.4%Neuroscience41.8%Multiple sclerosis37.5%Chemistry30.7%Pharmacology27.2%Mathematics27.1%Biochemistry27.1%Radiology23.9%Physics23.9%Statistics22.5%Bioinformatics21.9%Intensive care medicine21.7%Endocrinology21.5%Anesthesia20.1%

Primary Research Areas

Clinical Neurology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

CLINICAL NEUROLOGY

Rank68/296

IndexSCIE

JCISCIE2026

CLINICAL NEUROLOGY

Rank67/296

IndexSCIE

Category	Index	Rank	Quartile
CLINICAL NEUROLOGY	JCRSCIE	68/296	Q1
CLINICAL NEUROLOGY	JCISCIE	67/296	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF4

Articles / Year97

Total Citations44

2025

IF4.1

Articles / Year134

Total Citations500

2024

IF4.7

Articles / Year102

Total Citations841

2023

IF5.9

Articles / Year94

Total Citations1,284

2022

IF6.43

Articles / Year80

Total Citations1,659

Year	Impact Factor	Articles / Year	Total Citations
2026	4	97	44
2025	4.1	134	500
2024	4.7	102	841
2023	5.9	94	1,284
2022	6.43	80	1,659
2021	6.57	106	3,333
2020	5	77	2,409
2019	3.58	76	3,192
2018	4.75	73	3,773
2017	—	28	1,712
2016	—	51	1,626
2015	—	37	1,943

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #3,425Scopus Q1SCImago Profile

Scopus Coverage:2008-2026

•

Scopus Broad Areas:MedicineNeurosciencePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q1

1.243

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

3.57

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,585 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,086

3-Year Documents274

Citable Documents261

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate43.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

NeurologyQ1

Neurology (clinical)Q1

PharmacologyQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 2.1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

2区 (Zone 2)Medicine

Minor Category (Specific Field):

3区CLINICAL NEUROLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Therapeutic Advances in Neurological Disorders (abbr: THER ADV NEUROL DISO, ISSN: 1756-2856) is a peer-reviewed international scholarly journal in the field of CLINICAL NEUROLOGY, published by SAGE Publications Ltd in England. The periodical holds a Journal Impact Factor (JIF) of 4.00, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.243 (Q1), an H-index of 81.

The journal enforces rigorous peer evaluation with an annual output of approximately 93 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,585 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.